A naturally occurring predatory bacterium can work with the immune system to clear multi-drug resistant Shigella infections in zebrafish.
It is the first time the predatory bacterium Bdellovibrio bacteriovorus has been successfully used as an injected anti-bacterial therapy and represents an important step in the fight against drug-resistant infections, or ‘superbugs’.
Shigella infection is responsible for over 160 million illnesses and over 1 million deaths every year – and is a common cause of ‘travellers’ diarrhoea.’ Cases of drug-resistant Shigella are also on the rise as, although the diarrhoea usually clears up without treatment, antibiotics are often used even in mild cases to stop the diarrhoea faster. Resistance to antibiotics has prompted a team of researchers from Imperial College London and Nottingham University to look to the natural environment for creative solutions to this problem.
‘PREDATORY ACTION’ – ABOUT THE STUDY
To investigate Bdellovibrio’s ability to control drug resistant Gram-negative infections, researchers injected zebrafish larvae with a lethal dose of Shigella flexneri strain M90T which is resistant to both streptomycin and carbenicillin antibiotics. Bdellovibrio was then injected into the larvae’s infection site, and a decrease in the number of Shigella was seen. In the absence of Bdellovibrio, zebrafish were unable to control the replication of Shigella and levels of the bacteria rose.
Co-lead author Dr Serge Mostowy from the Department of Medicine at from Imperial College London said: “This study really shows what a unique and interesting bacterium Bdellovibrio is as it presents this amazing natural synergy with the immune system and persists just long enough to kill prey bacteria before being naturally cleared. It’s an important milestone in research into the use of a living antibiotic that could be used in animals and humans.”
Bdellovibrio can invade and kill a range of Gram-negative bacteria, such as E. coli and Salmonella, in the natural environment. Previous research has shown that it can reduce pathogen numbers in the stomach of chickens when taken as an oral therapy, but there is growing need to develop therapies to target infections in wounds and organs. Successful use of Bdellovibrio highlights its potential uses in tackling a range of drug-resistant Gram-negative bacterial infections that can develop in hospital patients.
The urgent requirement for new antimicrobials calls for increasingly creative solutions
– Dr Alex Willis
Co-lead author from Imperial’s Department of Medicine
Dr Mostowy and co-lead author Dr Alex Willis from the Department of Medicine at Imperial said: “The urgent requirement for new antimicrobials calls for increasingly creative solutions. The zebrafish has been a fantastic model for us to generate rapid understanding of how a living antibiotic can work in an animal. Our findings here provide the basis for testing Bdellovibrio in higher vertebrates and ultimately, humans.
“The translucent zebrafish facilitates powerful microscopy that enables striking understanding more difficult to achieve using other animal models. Being able to visualise the infection as well as the predatory bacteria and host immune cells has been invaluable in helping us understand how Bdellovibrio can function in an animal.”
Professor Liz Sockett, co-lead author from The University of Nottingham said: “This has been a truly ground-breaking collaboration that shows therapeutic Bdellovibrio in action inside the translucent living zebrafish. The predatory action of the Bdellovibrio breaks the Shigella-pathogen cells and this stimulates the white blood cells; redoubling their ‘efforts’ against the pathogen and leading to increased survival of the zebrafish ‘patients’.”
Remarkably, Bdellovibrio is also able to reduce pathogen load in immunocompromised zebrafish larvae that have been depleted of white blood cells. However, survival is significantly greater in immune-competent zebrafish, showing that Bdellovibrio’s maximum therapeutic benefit comes from its ability to work cooperatively with the host’s own immune system.
Dr Michael Chew, Science Portfolio Advisor at Wellcome said: “It may be unusual to use a bacterium to get rid of another, but in the light of the looming threat from drug resistant infections the potential of beneficial bacteria-animal interactions should not be overlooked. We are increasingly relying on last line antibiotics, and this innovative study demonstrates how predatory bacteria could be an important additional tool to drugs in the fight against resistance.”
The Latest on: Living antibiotic
via Google News
The Latest on: Living antibiotic
- Effects on Antibiotic Resistance with Silver-Releasing Glasson January 23, 2020 at 11:25 pm
2 This is an issue for surgical implants and medical implant failure is often a result of infections caused by bacteria living on the surfaces of implants. These biofilms can be hard to eliminate by ...
- Stressed-out Dust is Sharing Antibiotic Resistance Geneson January 23, 2020 at 1:03 pm
Indoor dust is evolving — and not in a good way. A new Northwestern Engineering study is the first to find that bacteria living in household dust can spread antibiotic resistance genes. Although most ...
- Bacteria hiding in indoor dust could spread antibiotic resistanceon January 23, 2020 at 11:00 am
Bacteria enter our homes, gyms and workspaces by hitching rides on our skin or blowing in through an open door. Once inside, these invader microbes might help indoor germs in the surrounding dust ...
- Dust in home may be spreading SUPERBUGS by carrying genes that give antibiotic resistanceon January 23, 2020 at 11:00 am
The findings of the study showed that dust in modern homes were a 'reservoir' of antibiotic-resistant genes. The team of scientists said buildings were therefore a possible place in which threatening ...
- Are probiotics a waste of money?on January 22, 2020 at 12:59 am
This article is reprinted by permission from NextAvenue.org. Humans are made up of over 100 trillion microbes, with the majority of them living in our large intestine. These microbes — fungi, yeast, ...
- Save antibiotics for serious infection - and future generationson January 15, 2020 at 11:15 am
Antibiotic use in New Zealand remains too high by international standards and needs to be curtailed to protect future generations from resistant bacteria, writes Mark Thomas of the University of ...
- Israeli docs strike big blow to antibiotic-resistant 'superbugs'on January 13, 2020 at 6:13 am
Like all living organisms, germs like bacteria develop defenses against hostile elements in their environment. One common tactic is “tolerance,” that is, lying dormant during antibiotic treatment. In ...
- Israeli Doctors Find Treatment for Antibiotic-Resistant Bacteriaon January 13, 2020 at 5:02 am
Hebrew University Like all living organisms, germs like bacteria develop defenses against hostile elements in their environment. One common tactic is “tolerance”, that is, lying dormant during ...
- FDA to shift more livestock antibiotics to prescription-onlyon January 10, 2020 at 8:38 am
in turn reducing their need to reach for an antibiotic. This may include talking with a veterinarian to identify husbandry, housing or production practices that could be improved to reduce disease — ...
via Bing News